Movement Alert｜INNOCARE Falls 5.73% in Regular Trading, Biotech Sector Broadly Weak as National Insurance Negotiation Concludes

Market Focus

Sep 10

On September 10, INNOCARE fell 5.73% in regular trading, trading at HK$13.65/share, with turnover of HK$71.94 million. The decline came amid broad-based selling across the biotech sector following the conclusion of the national medical insurance directory negotiation and the inaugural commercial insurance innovative drug catalog price negotiation on September 9.

The five-day national negotiation concluded with 124 drugs entering basic medical insurance pricing discussions and 12 innovative drugs participating in commercial insurance catalog negotiations. INNOCARE was among the companies that entered negotiations on the third day. While the dual-catalog mechanism — linking basic medical insurance with commercial insurance — is seen as structurally positive for innovative drug companies, the completion of the event appears to have triggered a broad sector sell-off.

Within the Biotechnology sector, the overall performance was weak. Among individual stocks, INNOVENT BIO fell 3.11%, AKESO fell 1.16%, 3SBIO fell 3.78%, BEONE MEDICINES fell 0.77%, and EVEREST MED fell 7.62%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/news/1122873102"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122873102\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122873102?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-10 13:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122873102","market":"us","top_or_hot":-1,"title":"Movement Alert｜INNOCARE Falls 5.73% in Regular Trading, Biotech Sector Broadly Weak as National Insurance Negotiation Concludes","media":"Market Focus","content":"<p><p>On September 10, INNOCARE fell 5.73% in regular trading, trading at HK$13.65/share, with turnover of HK$71.94 million. The decline came amid broad-based selling across the biotech sector following the conclusion of the national medical insurance directory negotiation and the inaugural commercial insurance innovative drug catalog price negotiation on September 9.</p><p>The five-day national negotiation concluded with 124 drugs entering basic medical insurance pricing discussions and 12 innovative drugs participating in commercial insurance catalog negotiations. INNOCARE was among the companies that entered negotiations on the third day. While the dual-catalog mechanism — linking basic medical insurance with commercial insurance — is seen as structurally positive for innovative drug companies, the completion of the event appears to have triggered a broad sector sell-off.</p><p>Within the Biotechnology sector, the overall performance was weak. Among individual stocks, INNOVENT BIO fell 3.11%, AKESO fell 1.16%, 3SBIO fell 3.78%, BEONE MEDICINES fell 0.77%, and EVEREST MED fell 7.62%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜INNOCARE Falls 5.73% in Regular Trading, Biotech Sector Broadly Weak as National Insurance Negotiation Concludes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜INNOCARE Falls 5.73% in Regular Trading, Biotech Sector Broadly Weak as National Insurance Negotiation Concludes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-10 13:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 10, INNOCARE fell 5.73% in regular trading, trading at HK$13.65/share, with turnover of HK$71.94 million. The decline came amid broad-based selling across the biotech sector following the conclusion of the national medical insurance directory negotiation and the inaugural commercial insurance innovative drug catalog price negotiation on September 9.</p><p>The five-day national negotiation concluded with 124 drugs entering basic medical insurance pricing discussions and 12 innovative drugs participating in commercial insurance catalog negotiations. INNOCARE was among the companies that entered negotiations on the third day. While the dual-catalog mechanism — linking basic medical insurance with commercial insurance — is seen as structurally positive for innovative drug companies, the completion of the event appears to have triggered a broad sector sell-off.</p><p>Within the Biotechnology sector, the overall performance was weak. Among individual stocks, INNOVENT BIO fell 3.11%, AKESO fell 1.16%, 3SBIO fell 3.78%, BEONE MEDICINES fell 0.77%, and EVEREST MED fell 7.62%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09969","symbol_name":"诺诚健华","start_time":0,"source_url":"","article_id":"1122873102","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122873102","pubTimestamp":1789016900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 10, INNOCARE fell 5.73% in regular trading, trading at HK$13.65/share, with turnover of HK$71.94 million. The decline came amid broad-based selling across the biotech sector following...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09969":"诺诚健华"},"translate_title":"走势警报|诺诚健华常规交易下跌5.73%，国家保险谈判结束，生物技术板块普遍疲软","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09969":1},"content_text":"On September 10, INNOCARE fell 5.73% in regular trading, trading at HK$13.65/share, with turnover of HK$71.94 million. The decline came amid broad-based selling across the biotech sector following the conclusion of the national medical insurance directory negotiation and the inaugural commercial insurance innovative drug catalog price negotiation on September 9.The five-day national negotiation concluded with 124 drugs entering basic medical insurance pricing discussions and 12 innovative drugs participating in commercial insurance catalog negotiations. INNOCARE was among the companies that entered negotiations on the third day. While the dual-catalog mechanism — linking basic medical insurance with commercial insurance — is seen as structurally positive for innovative drug companies, the completion of the event appears to have triggered a broad sector sell-off.Within the Biotechnology sector, the overall performance was weak. Among individual stocks, INNOVENT BIO fell 3.11%, AKESO fell 1.16%, 3SBIO fell 3.78%, BEONE MEDICINES fell 0.77%, and EVEREST MED fell 7.62%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}